Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

Medicare Part D plans can only cover obesity ... Lilly and its main rival in the obesity-drug race, Denmark's Novo Nordisk (NVO) (DK:NOVO.B), are conducting trials to evaluate GLP-1 drugs as ...

Mehmet Oz, Trump’s pick to run the Centers for Medicare and Medicaid Services ... the kitchen garden before sending more money to Denmark.” Kennedy’s position is also seemingly at odds ...